Edition:
United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

84.64USD
25 Sep 2017
Change (% chg)

$0.73 (+0.87%)
Prev Close
$83.91
Open
$83.87
Day's High
$84.65
Day's Low
$83.81
Volume
1,235,220
Avg. Vol
962,949
52-wk High
$86.71
52-wk Low
$64.25

Conterno, Enrique 

Mr. Enrique A. Conterno is Senior Vice President and President - Lilly Diabetes and President - Lilly USA of the Company. Mr. Conterno became president of the diabetes business unit on November 1, 2009. The business unit, which becomes operational on January 1, 2010, enhances the company’s diabetes focus. Since January 2009, he had served as president of Lilly USA. He is a member of Lilly's operations committee and senior management council. He earned a master's of business administration degree at Duke University in 1992. He earned his bachelor’s degree in mechanical engineering from Case Western Reserve University in 1989. He joined Lilly as a sales representative in 1992. From 1993 to 1995, he held as a financial analyst, marketing associate, and business development manager. In 1996, Conterno became sales and marketing director for the Peru affiliate, and in 1998, he became the sales and marketing director for Lilly's affiliate in Brazil. In 2000, he was named executive director of marketing for the intercontinental region and Japan. He served as president and general manager for Lilly’s operations in Mexico in 2003, and was named vice president of Lilly USA's neuroscience business unit in July 2006. In June 2008, he was named senior vice president of health care professional markets for Lilly USA.

Basic Compensation

Total Annual Compensation, USD 1,409,330
Restricted Stock Awards, USD 2,200,000
Long-Term Incentive Plans, USD --
All Other, USD 979,086
Fiscal Year Total, USD 4,588,420

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 6,928 169,875.00